Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population-Based Cohort Study.

In this subgroup, treatment with clopidogrel was associated with a numerically lower risk of cardiovascular death, MI, or stroke versus placebo, and although the difference did not reach statistical significance (14.5% versus 16.2%, respectively, relative risk 0.89, 95% CI 0.71–1.11), the absolute risk reduction was similar to the overall study population [ 28 ].

also in 111,027 other papers